510(k) Report

510(k) · Cleared

Cleared

10 X 10 Vision

K091928510(k) TraditionalCleared Jun 16, 2010351-day reviewClass II21 CFR 892.1680

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bioptics, Inc. · MWP Cabinet, X-Ray System

Cleared on Jun 16, 2010 as substantially equivalent to K021113 (Fischer Imaging Corp., 2002) after a 351-day review. Its family tree reaches back 1 generation to 2002.

Decided
Jun 16, 2010
Review
351 days
Class
Class II
Product code
MWP
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K021113 (2002). No later device cites it as a predicate yet.

K021113 · Mammopath · Fischer Imaging Corp. · 20022000200220042006200820102012
K021113 · Mammopath · Fischer Imaging Corp. · 20020
  1. Root · 1 generation backK021113 MammopathFischer Imaging Corp. · 2002
  2. This deviceK091928 10 X 10 VisionBioptics, Inc. · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K021113MammopathFischer Imaging Corp.2002—
0 (this device)K09192810 X 10 VisionBioptics, Inc.2010—
FIG. 1 — Lineage of K091928, 2002–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MWP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new MWP device

  1. #1 K202713 TrueView 100 Proscore 7.9 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K021113Mammopath
Summary page 1
…X 10 VISION, is substantially equivalent to the MammoPath® [registered trade mark of Fischer Imaging Technologies, Denver, Colorado- Stationary X-Ray System, K021113. B. DEVICE DESCRIPTON - as required by 807.92(a)(4) The 10 X 10 VISION will be marketed as a digital specimen…
Fischer Imaging Corp.2002—

Also cleared against K021113: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • 1 other device also cites its predicate K021113.

How does its category compare?

All MWP devices

MWP Cabinet, X-Ray System: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · MWP

2in 2023

2007: 22008: 12009: 12010: 12011: 12012: 12016: 12017: 12018: 12019: 52020: 22021: 42023: 2
2007high 5 (2019) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MWP

154in 2021

2019: 104 days median2021: 154 days median
2007high 154 (2021) · low 104 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MWP

No recall names MWP since 2007.

Adverse event reports per year · MWP

1in 2025

2018: 12021: 32022: 12023: 32024: 12025: 1
2007high 3 (2021) · low 0 (2007)2025

MAUDE reports naming product code MWP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
20091—00
20101—00
20111—00
20121—00
20130—00
20140—00
20150—00
20161—00
20171—00
20181—01
2019510400
20202—00
2021415403
20220—01
20232—03
20240—01
20250—01
20260—0—

What is it indicated for?

The Bioiptics 10 X 10 VISION is a digital specimen radiography add-on upgrade to previously released cabinet x-ray systems. The 10 X 10 Vision is used for digital specimen radiography to provide rapid verification that the correct tissue has been excised during excisional or percutaneous biopsy. The 10 X 10 Vision is excluded from any use in in-vivo diagnostic or screening mammography applications.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K091928: 10 X 10 Vision.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K091928

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026